Sees FY24 revenue down 0.25% to up 1.75%, consensus $23.85B. Sees FY24 adjusted organic sales growth flat to up 2%. The company said, “3M initiated the following full-year 2024 expectations. Beginning in the second quarter of 2024, Solventum’s historical earnings results will be reported within 3M’s financial statements as discontinued operations. The 2024 earnings outlook below reflects Solventum’s net income as discontinued operations for the full year, including the first quarter of 2024.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMM:
- 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
- Options Volatility and Implied Earnings Moves This Week, April 29 – May 02, 2024
- Is MMM a Buy, Before Earnings?
- 3M price target lowered to $110 from $118 at JPMorgan
- Exact Sciences names Aaron Bloomer as CFO, effective May 15